The mechanism whereby long-term exposure of the β-cell to fatty acids alters the β-cell response to glucose is not known. We hypothesized that fatty acids may alter β-cell function by changing the expression level of metabolic enzymes implicated in the regulation of insulin secretion, in particular acetyl-CoA carboxylase (ACC). This enzyme catalyzes the formation of malonyl-CoA, a key regulator of fatty acid oxidation. Using the β-cell line INS-1 as a model, the results show that the polyunsaturated fatty acid linoleate (C18:2) inhibited both basal and glucose-stimulated ACC mRNA induction. The inhibition was detected by 4–6 h, and a maximal 60% effect occurred at 12 h after cell exposure to the fatty acid. Linoleate, as glucose, did not modify the half-life of the ACC transcript. Prolonged exposure of INS-1 cells to linoleate also inhibited ACC protein accumulation at low and high glucose. The saturated fatty acids myristate (C14:0), palmitate (C16:0), and stearate (C18:0) were also effective as well as the monounsaturated oleate (C18:1) and the short-chain fatty acids butyrate (C4:0) and caproate (C6:0); longchain ω3 fatty acids were ineffective. The threshold concentration for long-chain fatty acids was 0.05 mmol/l, and maximal inhibition occurred at 0.3 mmol/l. 2-bromopalmitate, a nonmetabolizable analog, had no effect, suggesting that fatty acids must be metabolized to change ACC gene expression. Prolonged exposure of INS-1 cells to palmitate, oleate, and linoleate markedly altered the glucose-induced insulin response, resulting in high basal insulin release and a suppression of glucose-induced insulin secretion. This was associated with an exaggerated (twofold to threefold) rate of fatty acid oxidation at all tested glucose concentrations. The data provide a possible mechanism to at least partially explain how fatty acids cause β-cell insensitivity to glucose, i.e., by downregulating ACC with a resulting exaggerated fatty acid oxidation.
Skip Nav Destination
Article navigation
Original Articles|
March 01 1997
Long-Chain Fatty Acids Inhibit Acetyl-CoA Carboxylase Gene Expression in the Pancreatic β-Cell Line INS-1 Free
Thierry Brun;
Thierry Brun
Molecular Nutrition Unit, Department of Nutrition, University of Montreal Medical School
Montreal, Quebec, Canada
Search for other works by this author on:
Françhise Assimacopoulos-Jeannet;
Françhise Assimacopoulos-Jeannet
Département de Biochimie Médicale, Centre Médicale Universitaire, University of Geneva
Geneva, Switzerland
Search for other works by this author on:
Barbara E Corkey;
Barbara E Corkey
Division of Diabetes and Metabolism, Boston University Medical School
Boston, Massachusetts
Search for other works by this author on:
Marc Prentki
Marc Prentki
Molecular Nutrition Unit, Department of Nutrition, University of Montreal Medical School
Montreal, Quebec, Canada
Search for other works by this author on:
Address correspondence and reprint requests to Dr. R.A. Rizza, Endocrine Research Unit, Mayo Clinic, 200 First St. S.W., Rochester, MN 55905.
1
ACC, acetyl-CoA carboxylase; BSA, bovine serum albumin; CPT-1, carnitine palmitoyl transferase 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; KRB, Krebs-Ringer bicarbonate; LC CoA, long-chain acyl-CoA esters; MCC, β-methylcrotonoyl-CoA carboxylase; PC, pyruvate carboxylase; PCC, propionyl-CoA carboxylase.
Diabetes 1997;46(3):393–400
Article history
Received:
June 25 1996
Revision Received:
October 31 1996
Accepted:
October 31 1996
PubMed:
9032094
Citation
Thierry Brun, Françhise Assimacopoulos-Jeannet, Barbara E Corkey, Marc Prentki; Long-Chain Fatty Acids Inhibit Acetyl-CoA Carboxylase Gene Expression in the Pancreatic β-Cell Line INS-1. Diabetes 1 March 1997; 46 (3): 393–400. https://doi.org/10.2337/diab.46.3.393
Download citation file:
223
Views